Sarissa Capital Acquisition Corp.

Sarissa Capital Acquisition Corp. (Nasdaq: SRSA) is a blank-check company sponsored by Sarissa Capital Management LP, the healthcare-focused investment firm led by Alex Denner. The SPAC completed its initial public offering in 2020 and targets the healthcare and biopharmaceutical sector, consistent with Sarissa Capital's long-standing investment focus on life sciences and pharmaceutical companies. As of its 10-Q filing dated August 12, 2021, the company remained in its search phase, actively seeking a qualifying business combination target. Sarissa Capital's deep sector expertise positions SRSA within the growing cohort of sponsor-led healthcare SPACs pursuing deals in therapeutics and biotech. Sign up for full data on SpacDesk to access SRSA's complete filing history, timeline, and deal-status tracking in one place.